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Abstract The 48 kDa trigger factor (TF) of E. coli was shown 
to be a peptidyl-prolyl cisltrans isomerase (PPIase). Its location 
on a ribosomal particle is unique among the PPIases described so 
far, and suggests a role in de novo protein folding. The trigger 
factor was investigated with regard to a domain carrying the 
catalytic activity. An enzymatieally active fragment could be 
isolated after proteolysis by subtifisin. The resulting polypeptide 
was analysed by N-terminal sequencing and MALDI-TOF mass 
spectrometry revealing an 11.8 kDa fragment of TF encompass- 
ing the amino acid residues Arg-145 to Glu-251. The nucleotide 
sequence ncoding the amino acid residues Met-140 to Ala-250 
of the TF was cloned into vector pQE32. After expression in E. 
coli the resulting His-tagged polypeptide was isolated on an Ni 2+- 
NTA column. Subsequent digestion with subtifisin and anion- 
exchange chromatography ielded a TF fragment encompassing 
amino acids Gin-148 to Thr-249. This fragment may represent 
the catalytic core of TF since PPIase activity with a specificity 
constant kcat/Km of 1.3 ~1-1  s -l could be demonstrated when 
using Suc-Ala-Phe-Pro-Phe-NH-Np as a substrate. Moreover, 
as was observed for the complete, authentic TF the PPIase 
activity of the fragment was not inhibited by the peptidomacro- 
fide FK506. 
Key words: Limited proteolysis; Peptidyl-prolyl cis/trans 
isomerase; Trigger factor; E. coli 
1. Introduction 
The trigger factor protein was originally found assisting in 
the maintenance of the translocation-competent co formation 
of the precursor protein proOmpA (outer membrane protein 
A) in vitro [1]. It has been demonstrated that TF has a bind- 
ing affinity to this protein when going from a denaturant like 
urea to renaturation conditions by either dilution or dialysis 
[2]. Therefore, stoichiometric complexes of TF and proOmpA 
could be isolated [2,3]. Using genetically engineered strains of 
E. coli either over- or underproducing TF, however, the mem- 
brane transport of proOmpA was not affected [4]. Further, 
TF was detected at the 70S ribosome dissociating in a salt- 
dependent manner [5]. The binding was proved exclusively for 
the 50S subunit [5,6] known for covering the exit domain of 
the nascent polypeptide chain. 
Recently, it could be demonstrated that TF belongs to the 
peptidyl-prolyl cis/trans isomerases (PPIases) [6]. PPIases cat- 
*Corresponding author. Fax: (49) (345) 551 197 2. 
Abbreviations: TF, trigger factor; PPIase, peptidyl-prolyl cisltrans 
isomerase; PMSF, phenylmethylsulfonyl fluoride; BSA, bovine serum 
albumin; -NH-Np, 4-nitroanilide; Suc, succinyl; FKBP, FK506- 
binding protein. 
alyse the cis/trans isomerization of Xaa-Pro peptide bonds in 
oligopeptide derivatives [7] and proteins [8], thereby accelerat- 
ing conformational interconversions of segments of the poly- 
peptide backbone. They are currently divided into the unre- 
lated families of cyclophilins, FK506-binding proteins [9] and 
the parvulins [10,11]. The cyclophilins and FKBPs are char- 
acterised through their binding to cyclosporin A and FK506, 
respectively, thereby inhibiting their PPIase activity. The 
PPIase activity of TF was not affected at all by these effectors 
but its subsite specificity was found to be reminiscent of 
FKBPs [6]. A certain degree of sequence homology of an 
inner area of TF to FKBPs has also been reported [12]. 
Moreover, TF was successfully crosslinked to the nascent 
chains of either presecretory or non-signal sequence bearing 
proteins [13]. This association of TF to the nascent chains was 
no longer stable under high salt/puromycin conditions indicat- 
ing a binding affinity to the translating ribosome. 
Interestingly, TF was also described to be involved in pro- 
tein degradation in complex with GroEL/GroES [14]. The 
degradation of an artificial protein was retarded in TF re- 
duced cells while in TF overproducing cells the entire full- 
length model protein was hardly detectable because of its 
rapid degradation by proteases. Thus, TF could be a rate- 
limiting component in the degradation of abnormal proteins. 
TF accelerates effectively the trans to cis isomerization of a 
model protein [6]. As was calculated via published methods 
about 5% of all peptidyl-prolyl bonds known in the spatial 
structure are in the cis conformation i native proteins [15,16]. 
The trans to cis isomerization is often the rate limiting step 
during the refolding of polypeptides provided that there is a 
cis prolyl residue in the native state [8,17,18]. The PPIases 
have been proved to catalyse these slow folding steps in vitro 
using several substrate proteins [8]. For cellular folding only 
sparse evidence for an involvement of PPIases has been given. 
Thus, a role of cyclophilins and FKBPs in maturation of two 
bacterial uciferases after their translation in a reticulocyte 
lysate in vitro was demonstrated [19]. Using cyclosporin A, 
the involvement of cyclophilins in proper folding of transfer- 
rin in hep G2 cells [20] and more recently the contribution of 
a mitochondrial cyclophilin in folding of newly imported pre- 
cursor proteins [21,22] could be shown. The occurrence of TF 
at the E. coli ribosome could be an indication of the involve- 
ment of PPIases in de novo folding of proteins. However, it 
remains an open question whether the high catalytic activity 
of TF toward proteinaceous substrates i brought about by 
utilising more extended subsite interactions. In this respect he 
12 kDa human cytosolic FKBP12 represents he minimal cat- 
alytic core of the FKBP-like PPIases. The additional contact- 
ing sites may be provided by amino acid regions flanking 
the putative catalytic domain of TF. Alternatively, the large 
number of nonconserved amino acids in the FKBP-like re- 
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gion may easily cause substantial alterations in subsite speci- 
ficity. 
In this study, we isolated a fragment of TF subsequent to 
limited digestion of the native protein with subtilisin. Evi- 
dence is provided by N-terminal sequencing, molecular mass 
determination and overexpression that this fragment repre- 
sents the PPIase active core of TF. The secondary structures 
of the authentic TF and the catalytically active fragment of 
TF were compared by CD spectroscopy. 
2. Materials and methods 
2.1. Materials 
Subtilisin Carlsberg (type VIII bacterial, ot 72H0115) and throm- 
bin from bovine plasma (lot 36F9472) were from Sigma (Deisenhofen, 
Germany). The substrates (Suc-Ala-Xaa-Pro-Phe-NH-Np, Suc-Ala- 
Ala-Pro-Arg-NH-Np) were purchased from Bachem (Heidelberg, 
Germany). Peroxidase-conjugated goat anti-rabbit IgG was obtained 
from Sigma (Deisenhofen, Germany). Molecular mass markers, nitro- 
cellulose NC45 and buffers (HEPES, Tris) were from Serva (Heidel- 
berg, Germany). Polyclonal antiserum against rigger factor was ob- 
tained from rabbit after immunisation with trigger factor fragments 
(Pab Productions, Herbertshausen, Germany). Trigger factor was iso- 
lated from E. coli cell extracts as described [6]. The 70S ribosomes 
were a kind gift from K. Nierhaus. Restriction endonucleases, RNase 
A, lysozyme and T4 DNA ligase were purchased from Boehringer 
Mannheim (Germany). SureClone Ligation Kit, WTSequencing Kit 
and oligonucleotides were obtained from Pharmacia Biotech (Frei- 
burg, Germany). Sequencing-grade [z~S]dATP was from Amersham 
(Braunschweig, Germany). PrimeZyme polymerase was purchased 
from Biometra (Grttingen, Germany). 
2.2. Protein analysis 
N-terminal sequencing was carried out using an Applied Biosystems 
476 A gas-phase sequencer after desalting of the sample through re- 
versed-phase HPLC (Shimadzu LC-10A) on a Nucleosil 500-5 C3- 
PPN column (125X4 mm, guard column 11 x4  mm) from Macher- 
ey-Nagel (Dtiren, Germany). After gel filtration enzymatically active 
fractions were applied to the column equilibrated with 0.1% aqueous 
trifluoroacetic acid in 1% acetonitrile (v/v). The fragment of TF was 
eluted after 19 min running a gradient from 20 to 60% acetonitrile in 
0.1% trifluoroacetic acid within 40 min at 40°C. The flow rate was 
1 ml/min. Elution was monitored at wavelengths of 215 and 280 nm. 
The molecular mass of the fragment was determined using a MAL- 
DI-TOF Bruker Reflex mass spectrometer (Bremen, Germany) 
equipped with an N2-UV laser (337 nm). The matrix was sinapic 
acid. For calibration cytochrome c (bovine heart) was used as internal 
standard. 
Circular dichroism was measured using a Jasco J-710 spectropolari- 
meter (Tokyo, Japan). Far-UV measurements were carried out in a 
thermostatted 0.1 cm quartz cell using 0.005 M sodium phosphate 
(pH 7.0) at 25°C. The spectra were recorded 8 times and averaged. 
The protein concentrations were 8.2 and 25.1 pM for authentic TF 
and the fragment of TF, respectively. Data were analysed using the 
software from Jasco (Tokyo, Japan). Molar ellipticity was calculated 
using the mean residue molar concentration of TF and its active 
fragment. 
SDS-PAGE (15%) and immunoblotting was performed as pre- 
viously described [6]. 
Protein concentration was determined spectrophotometricaUy using 
the molar extinction coefficients at 280 nm (15930 M -1 cm -1 for TF 
and 6970 M -1 cm -1 for TF fragment) which were calculated from the 
primary structure according to Gill and Von Hippel [23]. 
2.3. Limited proteolysis of TF and isolation of the PPlase active 
fragment 
Trigger factor (4 I-tM) was incubated with subtilisin (0.15 ~tM) for 
8 h at 4°C. Proteolysis was stopped by adding 1 mM PMSF. For the 
following separation the SMART System from Pharmacia (Uppsala, 
Sweden) was used. A 50 pl sample was applied to a Superdex 75 
PC3.2/30 column (Pharmacia, Uppsala, Sweden) equilibrated with 
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0.01 M HEPES (pH 7.5), 0.15 M KC1, 0.015 M MgCI2. A flow rate 
of 40 /.tl/min was used. Fractions of 40 I.tl were collected. PPIase 
activity was determined with N-succinyl-Ala-Phe-Pro-Phe-p-nitroani- 
lide as substrate using samples of 20 Ixl of each fraction. Calibration 
was performed under the same running conditions using molecular 
weight marker proteins from Boehringer Mannheim (Germany). 
These proteins were bovine serum albumin (68 kDa), ovalbumin (45 
kDa), chymotrypsinogen A (25 kDa) and cytochrome c (12.5 kDa). 
The exclusion limit was determined using catalase (240 kDa). The 
temperature was maintained at 25°C during all runs. 
2.4. Molecular cloning, overexpression a d isolation of the trigger 
factor fragment 
The complete rig gene [4] was amplified by PCR using the chromo- 
somal DNA of the E. coli K12 strain DH5a and two primers corre- 
sponding to the 5' and 3' regions of the tig gene (5'-CAGTG- 
GATCCCCATGCAAGTTTCAGTTGAAACC-3'  and 5'- 
CCTGGCGTCGACGGGCCTTTGTGCG-3'). The resulting PCR 
product was ligated into vector pUC18 and transformed into E. coli 
strain K12 DH5a. One positive clone was obtained designated as 
TTtigl. After digestion of the TTtigl plasmid DNA with SphI and 
PstI a fragment of 330 bp containing the sequence coding for the 
amino acids 140-250 of TF was extracted from agarose gel using 
the Sephaglas BandPrep Kit (Pharmacia, Freiburg, Germany) and 
ligated into pQE32 (Qiagen, Hilden, Germany). The resulting plasmid 
was transformed into E. coli strain K12 M15 (pREP4). Recombinants 
were screened by restriction analysis and controlled by sequencing 
according to the procedure of the manufacturer. The expressed pro- 
tein contained an oligohistidine tag (6 X His) at its N-terminus fol- 
lowed by Gly, Ile, Arg and the chosen sequence of TF including the 
originally found cleaving site for subtilisin (Leu-144-Arg-145). There 
were four amino acids at the C-terminus that do not belong to the TF 
fragment isolated by digestion. For the recombinant protein they were 
also found to be cleaved off after digestion. 
After induction by IPTG, cells of 1 1 culture of the overexpressing 
strain K12 M15 were grown for 5 h at 37°C. Cells were harvested by 
centrifugation (6000 X g, 4°C, 10 min) and washed with 0.025 M phos- 
phate buffer (pH 8.0), 0.15 M NaC1. The cells were resuspended in
0.05 M phosphate (pH 8.0), 0.3 M NaC1 and passed through a French 
press (SLM Aminco, Buettelborn, Germany). Cell debris were re- 
moved by ultracentrifugation for 40 rain at 95800×g (Beckman, 
4°C). The supernatant was pooled and applied to an Ni2+-NTA col- 
umn (1 X2 cm, Qiagen, Hilden, Germany) equilibrated in the same 
buffer. Unspecifically bound material was washed off by 0.05 M phos- 
phate (pH 6.0), 0.3 M NaC1, 10% glycerine (v/v). Bound protein was 
eluted by a gradient of 0-0.5 M imidazole (60 ml total). Further 
purification of the enzymatically active fractions was achieved by 
gel filtration. After concentration a 1 ml sample was applied to a 
Superdex 75 16/60 HiLoad FPLC column (Pharmacia, Uppsala, Swe- 
den) equilibrated with 0.01 M HEPES (pH 7.5), 0.15 M KC1, 0.015 M 
MgC12. The trigger factor derivative luted at a flow rate of 0.8 ml/ 
min was over 95% homogeneous a verified by SDS-PAGE and Coo- 
massie staining. The obtained purified protein was cleaved by subtili- 
sin (2.3 IxM) within 1 min giving the final trigger factor fragment. 
Separation of this TF fragment from the protease was achieved by 
anion-exchange chromatography. The protein was loaded onto a 
Fractogel EMD DEAE-650(M) column (1 X 5 cm, Merck, Darmstadt, 
Germany) equilibrated with 0.01 M HEPES (pH 7.5). Using a 0-1 M 
KC1 linear gradient (80 ml total) the PPIase active fragment was 
eluted at 0.25 M KC1 while the protease was in the flow through 
fractions. 
2.5. Assay of PPIase activity and inhibitory studies 
PPIase activity of TF was determined using the protease-coupled 
assay as described previously [6,24]. Conditions of isomer specific 
proteolysis for substrates of the structure Suc-Ala-Xaa-Pro-Phe-NH- 
Np were reached using subtilisin at the final concentration f 2.3 ~M. 
Inhibition studies using FK506 were carried out as described [6]. 
The rapamycin stock solution was prepared in 50% ethanol. In the 
case of a prolonged incubation of TF with the helper protease in the 
assay (when measuring low PPlase activities, for example), thrombin 
(final concentration 460 NIH/ml) as isomer specific protease and Suc- 
Ala-Ala-Pro-Arg-NH-Np as substrate were used. In the coupled assay 
thrombin was proved to be proteolytically inactive towards TF. 
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3. Results 
3.1. Limited digestion of TF and isolation of an enzymatically 
active TF fragment 
As could be detected by Western blotting standard prepara- 
tions of TF sometimes showed a small amount of proteinac- 
eous impurity migrating in the SDS gel at about 13 kDa 
(compare with lane 2, Fig. 1A). Limited digestion of authentic 
TF with subtilisin generated a polypeptide with a similar mo- 
lecular mass on SDS-PAGE. However, the resulting digests 
were not homogeneous with respect o the product composi- 
tion when analysed by SDS-PAGE and Western blotting. 
Thus, the 13 kDa protein was the smallest of the derivatives 
ranging in molecular mass from 13 to 59 kDa. During a 
defined time of proteolysis the PPIase activity did not decrease 
but the authentic TF band disappeared and smaller cross-re- 
acting protein bands became visible instead. 
When subjecting to a high concentration of subtilisin (2.3 
~tM) which is sufficient for conditions of isomer specific pro- 
teolysis used in the PPIase assay, TF was readily digested to 
the 13 kDa fragment within the mixing time (10 s). The re- 
maining PPIase activity was not affected by subtilisin tested 
up to 30 min. In contrast, the ribosome bound form of TF 
was stable at least for 8 min when employing 70S particles to 
the same proteolysis conditions as was proved by Western 
blotting (Fig. 1B). Using thrombin as helper enzyme, un- 
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Fig. 1. Western blot analysis of trigger factor and its truncated var- 
iants. (A) Full length TF (lane l) was employed to limited digestion 
by subtilisin and the PPIase active fragment was isolated (lane 2). 
Cloning and overexpression f the corresponding fragment carrying 
a histidine tag was carried out. The recombinant fragment was en- 
riched by an Ni2+-NTA column (lane 3). After a following gel fil- 
tration step the purified protein was cleaved by subtilisin (2.3 ~tM, 
1 min). The final product was separated from subtilisin by analytical 
gel filtration using the SMART system (lane 4). (B) Limited diges- 
tion of 70S ribosomes by subtilisin. The 70S particles (37A260/ml) 
were incubated with subtilisin (2.3 laM) for various times. The reac- 
tion was stopped by PMSF (1 mM). Aliquots of 30 p_l were used 
for the SDS-PAGE and Western blotting. Heated SDS sample buf- 
fer was added and the sample was left at 95°C for 5 min. The incu- 
bation times of 70S with subtilisin were: dead time of mixing (about 
5 s, lane 2), 4 min (lane 3) and 8 min (lane 4). Lanes 1 and 5 are 
controls of 70S incubated with PMSF treated subtilisin. A polyclo- 
nal antibody raised against rigger factor fragments (lacking either 
46 or 58 amino acid residues ubsequent to the N-terminus) was 
used for the primary incubation step. 
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Fig. 2. Gel filtration after cleavage of authentic trigger factor by 
subtilisin. Trigger factor (4 ~tM) was incubated with subtilisin (0.15 
ktM) for 8 h at 4°C. An 50/.tl sample was then applied to a Super- 
dex 75 PC 3.2/30 column equilibrated with 0.01 M HEPES (pH 
7.5), 0.15 M KC1, 0.015 M MgCI~. A flow rate of 40 ~l/min was 
used. After an eluted volume of 1 ml fractions of 40 ~tl were col- 
lected. PPIase activity was determined using samples of 20 ~tl of 
each fraction. It is shown as a dotted line using arbitrary units 
(AU) per ml. Calibration was performed under the same running 
conditions using bovine serum albumin (67 kDa), ovalbumin (45 
kDa), chymotrypsinogen A (25 kDa) and cytochrome c (12.5 kDa), 
bound TF was not cleaved and displayed PPIase activity in 
a range comparable to that of the small fragment. 
To gain more information about the site of PPIase activity 
within the TF we isolated the short TF fragment. In Fig. 1A a 
Western blot of the authentic TF and the fragment after its 
isolation is shown (lanes 1,2). Isolation of the fragment was 
carried out following limited proteolysis of TF (4 txM) by 
subtilisin (0.15 ~tM) for 8 h at 4°C. After stopping the reaction 
by PMSF the mixture was separated by gel filtration (Fig. 2). 
PPIase activity was detected in protein fractions co-eluting 
with molecular masses of 56 and 29 kDa. The fractions har- 
bouring the main activity (29 kDa proteins, 13 kDa in SDS- 
polyacrylamide g l) were subjected to reversed-phase HPLC. 
Only a single peak was detected. The N-terminus of this frag- 
ment was homogeneous in automatic Edman degradation and 
was found to start with the amino acid sequence 
RKQQATWKEKDGAVEAEDRVTIDFTGSVDG. This se- 
quence is identical to an internal region of TF following 
Leu-144. Among several attempts this result was reproducible. 
Analysis by SDS-PAGE and Western blotting revealed a mo- 
lecular mass of 13 kDa (Fig. 1A, lane 2). For more detailed 
information the molecular mass was determined by MALDI- 
TOF mass spectrometry (Fig. 3). The experimental value of 
11 845.2 Da perfectly matched a region of TF which encom- 
passes residues 145-25l exhibiting a calculated molecular 
mass of 11 846.6 Da. 
Using HPLC for analysing the proteolysis products of TF, 
another fragment migrating at about 14 kDa on SDS-PAGE 
was also obtained besides ome higher molecular mass prod- 
ucts (23 and 24 kDa in SDS-polyacrylamide gel). The N-term- 
inal sequence of both the 23 and 24 kDa products which were 
largely separated by HPLC was again RKQQA as was found 
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Fig. 3. MALDI-TOF mass spectrum of the purified TF fragment generated by subtilisin cleavage of authentic TF. Cytochrome c (molecular 
mass 12361.4 Da) was used as internal standard. 
for the small active fragment. The amino acid sequence of the 
14 kDa product started with MQVSVE which is identical to 
the N-terminus of the authentic TF. This N-terminal fragment 
was not obtained by gel filtration whereas the 23 and 24 kDa 
products were co-eluted with a molecular mass of 56 kDa 
displaying the minor PPIase activity seen in Fig. 2. 
3.2. Molecular cloning, overexpression a d &olation of the 
enzymatically active domain of TF 
The PPIase active domain of TF was cloned and expressed 
in E. coli. Overexpression was controlled by SDS-PAGE and 
Western blotting (not shown). In addition to an N-terminal 
histidine tag the construct encompassed residues Met-140 to 
Ala-250 of TF. The cleaving site for subtilisin found via the 
experiments described above (Leu-144-Arg-145) was main- 
tained within the expressed fragment. Thus, after purification 
by an Ni2+NTA column the enriched protein (Fig. 1A, lane 3) 
was subjected to digestion by subtilisin (2.3 ~tM) for 1 min. 
The proteolysis provided an uniform product with regard to 
the recombinant fragment as monitored by SDS-PAGE (not 
shown). Larger amounts of the resulting protein were further 
purified as described in section 2. An analytical sample was 
applied to gel filtration providing a homogeneous protein 
(Fig. 1A, lane 4). The protein was eluted with a molecular 
mass of 29 kDa as was observed for the authentic fragment of 
TF. However, the molecular mass determined by MALDI 
mass spectrometry provided a value of 11 235.4 Da which is 
somewhat lower than that of the authentic fragment. N-term- 
inal sequencing revealed the amino acids QATWKEKDG. 
The molecular mass matched the fragment Gln-148 to Thr- 
249 of TF. In contrast to native TF, other cleaving sites must 
be accessible for subtilisin within the constructed protein. 
3.3. Enzymatic and structural properties 
In the PPIase assay using tetrapeptide-4-nitroanilides as 
substrates the recombinant PPIase domain of TF showed 
few if any changes in its enzymatic efficiency in comparison 
to authentic TF. The apparent value of k¢JK~ was deter- 
mined to be 1.3 ~tM -1 s -1 for the recombinant 11.2 kDa 
protein using Suc-Ala-Phe-Pro-Phe-NH-Np as substrate. 
Thus, the PPIase domain retains the magnitude of activity 
usually found for FKBPs. For the amino acid sequence region 
encompassing the PPIase domain a certain degree of homol- 
ogy with FKBPs was shown [12]. However, in contrast o 
other FKBPs authentic TF as well as the 11.8 kDa domain 
were not inhibited by the peptidomacrolide FK506, even when 
0 
E 
"E 
? 
...? 
® 
30 I I I 
25 -  
20 
15 
\ 
10 
5 
0 '\ ' ' ' ' 
-5 t \ / 
/ 
-10 
-15 I I L [ I 
200 210 220 230 240 250 
I I 
m 
260 
Wavelength (nm) 
Fig. 4. CD spectra of authentic TF ( - - )  and the recombinant 
PPIase domain of TF (--) in the far UV region. The mean residue 
molecular ellipticity is shown. The protein concentrations were 8.2 
~M for the whole TF and 25.1 p,M in the case of the fragment. CD 
measurements were carried out in 5 mM sodium phosphate (pH 
7.0) using 0.1 cm cells. 
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hFKBP I2  
TF 
1 GVQVET ISP  GDGRTFP .KR GQTCVVHYTG MLEDGKKFDS SRDRNKPFKF  48 
141 LDTLRKQQAT WKEKDGAVEA EDRVTIDFTG SV. DGEEFEG GKA. .SDFVL  187 
hFKBP I2  
TF 
49 MLGKQEVIRG WEEGVAQMSV GQRAKLT ISP  DYAYGATGHP G I IPPHATLV 98 
188 AMGQGRMIPG FEDGIKGHKA GEEFT IDVTF  PEEYHAENL . . . . .  KGKAAK 232 
hFKBP I2  
TF 
99 FDVELLKLE  107 
233 FA INLKKVEE RELPELTAEF  IKRFGVEDGS VEGLRAEVRK NMERELRAPS 282 
Fig. 5. Partial sequence of TF in comparison to human FKBP12 [12,38]. The amino acyl residues enclosed to the PPIase active fragment are 
underlined. Asterisks mark residues of hFKBP12 which are involved in FK506 binding [39]. Bold letters represent residues which are perfectly 
conserved among FKBPs [39]. 
assayed at micromolar concentrations of inhibitor. FKBPs are 
also sensitive to the structurally related macrolide rapamycin 
over the nanomolar range. However, TF was also not affected 
by rapamycin as assessed up to 3 p.M. 
The secondary structures of the authentic TF and the 
PPIase-domain were compared by far UV-CD spectroscopy 
(Fig. 4). As could be derived from the secondary structure 
prediction algorithm [25], the complete protein contains con- 
siderable more c~-helix in contrast to the fragment whereas the 
spectrum of the active domain shows a higher content of 13- 
sheet. 
4. Discussion 
Recently, some more data have been provided about the 
trigger factor originally discovered through its binding to a 
precursor protein and implication in membrane translocation. 
The intrinsic PPIase activity of this protein taken together 
with its presence at the ribosome and nascent polypeptide 
chains, respectively, is most attractive in the view of the de 
novo folding. 
Here we could establish a domain-like organization of TF, 
and were able to isolate the PPIase domain of the protein. 
A certain degree of homology to FKBPs has been reported 
for the domain of TF encompassing residues 142-241 [12]. 
Indeed, when TF which is 432 amino acids in length was 
subjected to digestion by subtilisin, a single remaining active 
fragment was generated. It matches the sequence region 
thought o express imilarity to FKBPs (Fig. 5). This isolated 
inner fragment of TF consisting of 107 amino acyl residues is 
comparable in length to many FKBPs, for example the human 
FKBP12 which also extends over 107 amino acids. Addition- 
ally, the expressed recombinant form was as active as the 
authentic fragment but consists of only 102 amino acyl resi- 
dues. Both the authentic and recombinant domain of TF 
showed a positive reaction with our anti-TF antibodies in 
Western blot experiments. The antibodies were originally pro- 
duced against runcated forms of TF lacking either 46 or 58 
amino acids subsequent to the N-terminus. However, in com- 
parison to the complete TF the antigen-antibody interaction 
appeared rather weak in the case of the TF domain. 
FKBPs are named due to their high affinity binding to 
FK506. However, neither the authentic TF nor the active 
domain was sensitive to FK506 and rapamycin, even when 
the inhibitors were applied at high concentrations. Some ami- 
no acid residues of the FK506 binding region of FKBP12 are 
conserved in the primary structure of TF but many are altered 
to closely related residues [12]. Site-directed mutagenesis has 
been carried out with hFKBP12 in order to define the residues 
participating in macrolide binding [26,27]. Thus, some muta- 
tions led to minor changes of the inhibitory constants of the 
protein but, as exemplified in the case of the highly conserved 
Asp-37 (numbered according to hFKBP12, see Fig. 5), sub- 
stitution through Val revealed a substantial increase in the Ki 
value from 0.6 nM to 350 nM [27]. In contrast to other 
FKBPs the TF of E. coli and the recently described TF of 
Campylobacter jejuni [28] contain a glutamate residue at this 
position. For the TF of C. jejuni, however, data about PPIase 
activity and possibly FK506 binding have not been available 
until now. The sequences of TFs from two other organisms 
identified by their sequence homology to E. coli TF also con- 
tain at this position (Asp-37 numbered according to 
hFKBP12) a glutamate residue [29,30]. 
There are some larger, multidomain FKBPs and also cyclo- 
philins found as constituents in high molecular mass steroid 
receptor complexes [31,32]. The FKBP52 (also known as 
HSP56, p59, FKBP59 or HBI) (reviewed in [33]) contains 
three domains which are homologous to the FKBP12 [34]. 
When chicken thymus HSP56, an analogue of the FKBP52, 
was digested by endoproteinase Lys C an active FK506 bind- 
ing domain of 17 kDa was obtained [35]. 
The stable active TF fragment generated by subtilisin treat- 
ment supports the idea of a domain structure of TF which 
was recently predicted using computer methods [12]. The link- 
ages between protein domains are often particularly suscepti- 
ble to proteolysis. Subtilisin is known as a protease having a 
broad subsite specificity [36,37]. Therefore, it is comprehensi- 
ble that proteins possibly are readily digested when employed 
in subtilisin treatment. In the case of TF at least the central 
domain remained after digestion by subtilisin while other do- 
mains were probably proteolysed. The observation of an N- 
terminal fragment of TF of 14 kDa by separating the proteo- 
lysis products using HPLC still confirms the hypothesis of a 
domain-like structure of TF. 
As was estimated from far UV-CD data the secondary 
structures of both the authentic TF and its active domain 
appeared completely different. The authentic TF contains con- 
siderable more m-helix. A relatively high content of s-helix 
within the entire TF was previously predicted from primary 
structure for the N-terminal domain of TF [12]. 
However, experimental evidence for a role of domains 
flanking PPIase cores is still scarce even if this type of en- 
122 G. Stoller et al./FEBS Letters 384 (1996) 117-122 
zymes dominates the PPIase families [9]. The isolated TF do- 
mains may provide an example where the functional analysis 
can be accomplished. 
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